Sinan Cheng

Sinan Cheng

Auto-generated profile, based on publicly available information

Sinan Cheng

School of Basic Medical Sciences Changzhi Medical College Changzhi Shanxi China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Microscopy and Microanalysis
Verified
Journal Article
Closed access
PDF file
SCSinan Cheng
Sinan Cheng
XLXinyao Li
Xinyao Li
YYYue Yuan
Yue Yuan
CJChenshuang Jia
Chenshuang Jia
LCLirong Chen
Lirong Chen
YHYingchun Hou
Yingchun Hou
ITGB1 (Integrin β1, CD29) is a member of the integrin family and has a role as a major adhesion receptor. Gastric cancer (GC) is an important cause of mortality worldwide, especially in China. As a potential cancer enhancer, the role ITGB1 plays in GC progression remains unclear. In the current study, our assay on the databases of tumoassociated gene expression and interaction found that the high expression of ITGB1 was closely correlated with the poor prognosis of GC patients. To explore the roles, ITGB1 plays in GC progression, and an ITGB1-deleted cell line (ITGB1−/−SGC7901) was generated using the CRISPR/Cas9 method. The tumor malignancy-associated cell behaviors and microstructures were detected, imaged, and analyzed using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), wound healing, transwell, scanning electron microscopy, laser scanning confocal microscopy, and others. The results indicated that ITGB1 deletion decreased the GC cell proliferation and motility, and inhibited motility-relevant microstructures, such as pseudopodia and filopodia, markedly in ITGB1-deleted SGC7901 cells. The analysis of STRING database and western blots indicated that ITGB1 contributes to the malignancy of GC mediated by Src-mediated FAK/PI3K/Akt signaling pathways. Taken together, the results showed that ITGB1 may be a potential targeting marker for GC diagnosis and therapy in the future.

1 April 2022 in Materials Today Advances
Verified
Journal Article
Open access
SCSinan Cheng
Sinan Cheng
ZLZheng Lu
Zheng Lu
YFYang Feng
Yang Feng
XZXuewei Zhao
Xuewei Zhao
RZRuixia Zhao
Ruixia Zhao
YHYingchun Hou
Yingchun Hou

15 October 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
YBYanghui Bi
Yanghui Bi
PCPengyu Chen
Pengyu Chen
SJShuya Jia
Shuya Jia
SJShiyan Jia
Shiyan Jia
ZLZhanhao Lian
Zhanhao Lian
SCSinan Cheng
Sinan Cheng
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex pathogenesis, necessitating the development of safe and effective therapeutic interventions. This study aimed to investigate the protective effects and underlying mechanisms of Aucubin (Auc) against dextran sulfate sodium (DSS)‐induced UC in mice. Using a DSS‐induced colitis model, we systematically evaluated the multifaceted effects of Auc by assessing the Disease Activity Index (DAI), colon length, histopathological changes, immunohistochemical staining, ELISA results, proteomic profiles, 16S rRNA sequencing data, and untargeted metabolomic analyses. Compared with the DSS group, Aucubin high‐dose (Auc‐H, 100 mg/kg) treatment significantly attenuated DSS‐induced body weight loss, DAI score elevation, and colon shortening (all p < 0.05). The therapeutic efficacy of Auc‐H was comparable to that of the positive control drug 5‐aminosalicylic acid (5‐ASA). Mechanistically, Auc restored intestinal barrier integrity by stimulating mucin 2 (Muc2) secretion and upregulating the expression of zonula occludens‐1 (ZO‐1) and Occludin, which in turn significantly reduced serum lipopolysaccharide (LPS) concentrations ( p < 0.001). Proteomic analysis identified 2180 DSS‐induced differentially expressed proteins, of which 679 were significantly counter‐regulated by Auc‐H, mainly involving the complement and coagulation cascades and immune‐inflammatory pathways. Furthermore, gut microbiota analysis showed that Auc promoted the growth of beneficial bacteria, improving microbial balance. Untargeted metabolomics further revealed that Auc‐H significantly restored the levels of 120 DSS‐induced differential metabolites, including 86 upregulated and 34 downregulated metabolites, among which were protective tryptophan‐derived indole metabolites ( p < 0.05). Consequently, Aucubin exhibits significant clinical potential in alleviating UC via a multifaceted mechanism. These effects include reduced inflammation, restored epithelial barrier integrity, and modulated microbial metabolism. These findings provide crucial experimental evidence supporting the potential application of Auc as a preventive therapy for UC.

30 January 2024
Verified
Preprint
Open access
SCSinan Cheng
Sinan Cheng
XLXinyao Li
Xinyao Li
YYYue Yuan
Yue Yuan
CJChenshuang Jia
Chenshuang Jia
LCLirong Chen
Lirong Chen
YHYingchun Hou
Yingchun Hou
ITGB1 (Integrin β1, CD29) is a member of the integrin family and roles as a major adhesion receptor. Gastric cancer (GC) is an important cause of mortality worldwide, especially in China. As a potential cancer enhancer, the roles ITGB1 plays in GC progression keep unclear. In the current study, our assay on the databases about tumor associated gene expression and interaction found that the high expression of ITGB1 was closely correlated with the poor prognosis of GC patients. To explore the roles ITGB1 plays in GC progression, an ITGB1 deleted cell line (ITGB1-/-SGC7901) was generated using CRISPR/Cas9 method. The tumor malignancy associated cell behaviors and microstructures were detected, imaged, and analyzed using MTT, wound healing, transwell, scanning electron microscope (SEM), laser scanning confocal microscope (LSCM) and others. The results indicated that ITGB1 deletion decreased the GC cell proliferation and motility, and inhibited motility relevant microstructures, such as pseudopodia and filopodia markedly in ITGB1deleted SGC7901 cells. The analysis of STRING database suggested that ITGB1 contributes to the malignancy of GC mediated by Src-mediated FAK/PI3K/Akt signaling pathways. Taken together, the results above showed that ITGB1 may be a potential targeting marker for GC diagnosis and therapy, and it enhances GC progression via Src-mediated FAK/PI3K/Akt signal pathway that needs further validation in future.